Advanced Cancer Therapeutics – Product Pipeline Review – 2012

Published : June 2012
No. of Pages : 43

Price:

Advanced Cancer Therapeutics – Product Pipeline Review – 2012

Summary

Global Market Direct’s pharmaceuticals report, “Advanced Cancer Therapeutics - Product Pipeline Review - 2012” provides data on the Advanced Cancer Therapeutics’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Advanced Cancer Therapeutics’s corporate website, SEC filings, investor presentations and featured press releases, both from Advanced Cancer Therapeutics and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Advanced Cancer Therapeutics - Brief Advanced Cancer Therapeutics overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Advanced Cancer Therapeutics human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Advanced Cancer Therapeutics with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Advanced Cancer Therapeutics’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Advanced Cancer Therapeutics’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Advanced Cancer Therapeutics in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Advanced Cancer Therapeutics’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Advanced Cancer Therapeutics.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Advanced Cancer Therapeutics and identify potential opportunities in those areas.

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Advanced Cancer Therapeutics Snapshot 5
Advanced Cancer Therapeutics Overview 5
Key Information 5
Key Facts 5
Advanced Cancer Therapeutics – Research and Development Overview 6
Key Therapeutic Areas 6
Advanced Cancer Therapeutics – Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products – Monotherapy 10
Advanced Cancer Therapeutics – Pipeline Products Glance 11
Advanced Cancer Therapeutics Clinical Stage Pipeline Products 11
Phase II Products/Combination Treatment Modalities 11
Phase I Products/Combination Treatment Modalities 12
Advanced Cancer Therapeutics – Early Stage Pipeline Products 13
Pre-Clinical Products/Combination Treatment Modalities 13
Advanced Cancer Therapeutics – Drug Profiles 14
3PO 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
ACT-GRO-777 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
CK37 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
HPV Vaccine 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
PFK-015 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
PU27 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
Advanced Cancer Therapeutics – Pipeline Analysis 20
Advanced Cancer Therapeutics – Pipeline Products by Therapeutic Class 20
Advanced Cancer Therapeutics – Pipeline Products By Target 21
Advanced Cancer Therapeutics – Pipeline Products by Route of Administration 22
Advanced Cancer Therapeutics – Pipeline Products By Mechanism of Action 23
Advanced Cancer Therapeutics – Recent Pipeline Updates 24
Advanced Cancer Therapeutics - Dormant Projects 25
Advanced Cancer Therapeutics - Discontinued Pipeline Products 26
Discontinued Pipeline Product Profiles 26
ACT-GRO-777 + Cytarabine 26
Advanced Cancer Therapeutics – Locations And Subsidiaries 27
Head Office 27
Advanced Cancer Therapeutics, Recent Developments 28
Advanced Cancer Therapeutics- Press Release 28
Dec 16, 2009: AS1411 Shows Activity In Kidney Cancer But AML Remains Priority 28
Oct 13, 2009: Antisoma''s AS1411 Gains US And EU Orphan Drug Status For Acute Myeloid Leukaemia 28
May 29, 2009: Antisoma Announces To Advance AS1411 In AML Based On Positive Phase II Data Presented At ASCO 29
Financial Deals Landscape 31
Advanced Cancer Therapeutics, Deals Summary 31
Advanced Cancer Therapeutics, Pharmaceuticals & Healthcare, Deal Details 32
Asset Transactions 32
Antisoma Announces Sale Of AS1411 To Advanced Cancer Therapeutics 32
Venture Financing 34
Advanced Cancer Therapeutics Raises $10 Million In New Investments 34
Advanced Cancer Therapeutics Raises Additional $0.25 Million In Seed Round Of Financing 35
Advanced Cancer Therapeutics Secures $0.025 Million In Seed Financing 36
Partnerships 37
Advanced Cancer Therapeutics Enters Into An Agreement With James Graham Brown Cancer Center 37
Licensing Agreements 39
Advanced Cancer Therapeutics Enters Into An Agreement With James Graham Brown Cancer Center 39
Advanced Cancer Therapeutics Enters Into Licensing Agreement With University Of Louisville 40
Advanced Cancer Therapeutics Enters Into Licensing Agreement With Brown Cancer Center 41
Appendix 42
Methodology 42
Coverage 42
Secondary Research 42
Primary Research 42
Expert Panel Validation 42
Contact Us 43
Disclaimer 43

List of Tables
Advanced Cancer Therapeutics, Key Information 5
Advanced Cancer Therapeutics, Key Facts 5
Advanced Cancer Therapeutics – Pipeline by Indication, 2012 8
Advanced Cancer Therapeutics – Pipeline by Stage of Development, 2012 9
Advanced Cancer Therapeutics – Monotherapy Products in Pipeline, 2012 10
Advanced Cancer Therapeutics – Phase II, 2012 11
Advanced Cancer Therapeutics – Phase I, 2012 12
Advanced Cancer Therapeutics – Pre-Clinical, 2012 13
Advanced Cancer Therapeutics – Pipeline By Therapeutic Class, 2012 20
Advanced Cancer Therapeutics - Pipeline By Target, 2012 21
Advanced Cancer Therapeutics – Pipeline By Route of Administration, 2012 22
Advanced Cancer Therapeutics – Pipeline Products By Mechanism of Action, 2012 23
Advanced Cancer Therapeutics – Recent Pipeline Updates, 2012 24
Advanced Cancer Therapeutics - Dormant Developmental Projects,2012 25
Advanced Cancer Therapeutics - Discontinued Pipeline Products, 2012 26
Advanced Cancer Therapeutics, Deals Summary 31
Antisoma Announces Sale Of AS1411 To Advanced Cancer Therapeutics 32
Advanced Cancer Therapeutics Raises $10 Million In New Investments 34
Advanced Cancer Therapeutics Raises Additional $0.25 Million In Seed Round Of Financing 35
Advanced Cancer Therapeutics Secures $0.025 Million In Seed Financing 36
Advanced Cancer Therapeutics Enters Into An Agreement With James Graham Brown Cancer Center 37
Advanced Cancer Therapeutics Enters Into An Agreement With James Graham Brown Cancer Center 39
Advanced Cancer Therapeutics Enters Into Licensing Agreement With University Of Louisville 40
Advanced Cancer Therapeutics Enters Into Licensing Agreement With Brown Cancer Center 41

List of Figures
Advanced Cancer Therapeutics – Pipeline by Indication, 2012 7
Advanced Cancer Therapeutics – Pipeline by Stage of Development, 2012 9
Advanced Cancer Therapeutics – Monotherapy Products in Pipeline, 2012 10
Advanced Cancer Therapeutics – Pipeline By Therapeutic Class, 2012 20
Advanced Cancer Therapeutics - Pipeline By Target, 2012 21

Advanced Cancer Therapeutics – Product Pipeline Review – 2012

Published By: Global Markets Direct

Price:

How to Purchase

Purchase products from our site in 5 easy steps. Please follow the description given below to complete your purchase process.

Step 1:

Select the report title of your interest, and Click on Buy Now button next to the Price option.

Step 2:

You will arrive at the Purchase page, where you will be requested to Signup (New User) or Login (Registered User). Please note that in-keeping with the security check on the website, you must submit your full details to avoid any inconvenience arising from incorrectly entered data or counterfeit information.

Step 3:

After SignUp/Login, you will arrive at the Online Invoice Page. Select a Payment option via various methods: Debit Card / Credit Card / by Invoice. MarketReportOnline accepts Visa, MasterCard, American Express and all major credit cards. MarketReportOnline uses ICICI, HDFC, Citibank, American Express & Paypal as our Online Payment Gateway Partners. Clicking on a payment option will take you to the corresponding Payment Gateway page.

Step 4:

Once at the Payment Gateway, please complete the Payment Process to purchase your desired report.

Step 5:

Once you have successfully completed the purchase process, you will receive a confirmation email. You will then either be able to download your report immediately (in PDF Format) from the Account Login button, or the report will be emailed to you directly, depending upon the agreement we have with the publisher. For Orders that are deliverable via email and placed after working hours, the delivery of the reports will be made on the next business day. Please note, if you select purchase by invoice, you will receive your report only once the payment has been received. If you have any queries about how to order, please Contact Us .

sales@marketreportsonline.com + 1 888 391 5441

Using our subscription option, you get access to market research reports and industry data of Industry Profiles market as per your needs. Get the best of Industry Profiles research reports by utilizing your research budgets in an optimum way.
More about our Subscription option

Get Email alerts about market research reports from industries and publishers of your interest: